EVM
Evommune
EVMN • NYSE
Evommune is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Luis C. Pena, with a market cap of $1.0B.
Market Cap$1.0B
CEOLuis C. Pena
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
EVM
Evommune FAQ
Common questions about Evommune
Evommune is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $2.1M.